Abstract
Marvin J Slepian and Jack G Copeland present their Viewpoint on the University of Arizona's experience with the CardioWest™total artificial heart (TAH-t) in patients with protracted refractory cardiogenic shock accompanying acute myocardial infarction. The authors assert that the TAH-t could provide a lifeline to patients whose prognosis would otherwise be bleak.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
